TickerFactsScreenerDevelopers

BioXcel Therapeutics, Inc. (BTAI) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2017: -$982.0K2018: $38.89M2019: $26.89M2020: $206.70M2021: $221.67M2022: $76.78M2023: -$56.51M2024: -$93.10M2025: -$95.46M-$95.46M
2017Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$95.46M-2.5%
2024-$93.10M-64.8%
2023-$56.51M-173.6%
2022$76.78M-65.4%
2021$221.67M+7.2%
2020$206.70M+668.5%
2019$26.89M-30.8%
2018$38.89M+4060.2%
2017-$982.0K—